Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone

BACKGROUND: Edaravone was approved as a new treatment for amyotrophic lateral sclerosis (ALS), although there are different opinions on its effectiveness. Magnetic resonance (MRI) measures appear promising as diagnostic and prognostic indicators of disease. However, published studies on MRI using to...

Descripción completa

Detalles Bibliográficos
Autores principales: Distaso, Eugenio, Milella, Giammarco, Mezzapesa, Domenico Maria, Introna, Alessandro, D’Errico, Eustachio, Fraddosio, Angela, Zoccolella, Stefano, Dicuonzo, Franca, Simone, Isabella Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357666/
https://www.ncbi.nlm.nih.gov/pubmed/33655342
http://dx.doi.org/10.1007/s00415-021-10495-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357666/
https://www.ncbi.nlm.nih.gov/pubmed/33655342
http://dx.doi.org/10.1007/s00415-021-10495-9

Ejemplares similares